MarketScreener roundup: abysmal trade deficit and massive share buybacks in the US; Novo Nordisk's valuation on a diet
The US is running a record trade deficit, fueled by the anticipation of tariffs, while US companies are taking advantage of the downturn to buy back their shares. At the same time, Novo Nordisk's...